Learn how to verify a multi-peptide blend certificate of analysis: per-component identity, net content vs labeled ratios, and red flags for a lone “blend purity” number — with GLOW, KLOW, and CJC+Ipamorelin examples. Research use only.
A single-analyte research-peptide certificate of analysis asks three core questions: identity, purity, and content for one sequence. A multi-peptide blend COA asks the same questions — then adds a fourth: whether every labeled component is accounted for, and whether the published ratio is composition evidence or only a storefront size string.
This page is the blend-specific companion to How to read a research-peptide COA. It does not rewrite the full single-SKU tutorial. Focus: component list → identity attribution → net content versus ratio → laboratory-portal verify. Worked examples use live Peptide Foundry lots for GLOW, KLOW, and CJC-1295 + Ipamorelin. Research use only.
Key points
- A blend COA is stronger when it resolves each labeled component, not only a single headline purity percentage.
- Workflow order: component list → per-component identity → net / ratio disclosure → lab-portal verify.
- HPLC peak attribution and mass spectrometry answer different identity questions; prefer both when available.
- Net peptide content may appear as a single total or as per-component milligram lines — do not invent splits a vendor has not published.
- Blend market names are not formulas; the same storefront word can map to different mass ratios across sellers.
- Research use only — not for human or veterinary use.
How a blend COA differs from a single-analyte COA
On a single-peptide lot, one main-peak HPLC purity figure and one MS identity call can describe the material with relatively little ambiguity. On a co-lyophilized multi-peptide vial, several sequences share the same cake. A lone “blend purity %” collapses that complexity into one number. It may still be useful when method, wavelength, lot, and lab are stated — but it does not prove every labeled component is present at the labeled mass.
Blend documentation therefore has to do more work:
- Name every component expected in the vial (or tie identity data clearly to that list).
- State the labeled mass ratio (for example
50mg/10mg/10mg) and treat it as a claim to verify, not as chemistry by itself. - Separate identity from purity from content — the same three-way split taught for single SKUs, applied per component when the laboratory reports that way.
- Disclose aggregate versus component-resolved content — a single net total is honest evidence; a fabricated per-component split is not.
Mixed-peptide impurity profiles can complicate a single UV purity integration. Demand clearer attribution on blend certificates rather than skipping documentation. Read what the issuing laboratory measured, then ask what stronger blend dossiers add.
Verification workflow for multi-peptide blends
Use this order on every blend lot. It extends the single-SKU checklist without replacing it.
- Batch-match the vial to the certificate. Lot string character for character. A reused “house” blend PDF applied across lots fails here.
- Confirm the component list. Count named peptides on label and COA (three for Peptide Foundry GLOW; four for KLOW; two for CJC-1295 + Ipamorelin). If the certificate names fewer analytes than the vial claims, stop.
- Read per-component identity evidence. Prefer MS / LC-MS for each expected molecular weight, and/or HPLC peak assignments to named components. “Identity: Pass” with no method is weak for a blend.
- Read net content and ratio disclosure. Compare labeled size string to measured net peptide content. Note whether net is a single total or split per component. Do not invent milligram lines the publisher did not print.
- Portal-verify at the laboratory. Use the access code on the issuing lab’s own portal — not only a supplier-hosted PDF.
- Read full QC panels as separate results when present (heavy metals, sterility, endotoxin, illicit screen). They do not replace identity or composition checks.
For named-lab expectations, ISO/IEC 17025 weighting, contaminant panels, and general red flags, see How to read a research-peptide COA. This page stays on blend-specific failure modes.
Per-component identity: HPLC attribution versus mass spectrometry
Identity on a blend is easy to over-claim. Two common laboratory patterns appear on research-peptide certificates:
HPLC peak attribution / HPLC-RTM
HPLC with UV at a stated wavelength (often 214 nm) separates UV-absorbing species under a stated method. When peaks are resolved and assigned, a laboratory can attribute retention-time matches to named components. Peptide Foundry’s published blend panels sometimes report identity as HPLC-RTM — Pass. That is a real method line — not the same evidence depth as a mass spectrum showing each expected molecular ion.
On a blend chromatogram, look for stated method and wavelength, labeled peak assignments to named peptides, whether purity is one main-peak percentage or component-resolved, and whether a chromatogram is attached at all. Unresolved or unlabeled peaks leave composition ambiguous even when headline purity looks high.
Mass spectrometry / LC-MS
MS checks observed mass against expected molecular weight for each sequence. For multi-component blends, the stronger pattern is per-component mass confirmation — not a single vague “MS confirmed” stamp on the mixture. LC-MS pairs separation with mass assignment when UV peaks alone are hard to attribute.
HPLC purity and MS identity remain orthogonal. A high HPLC percentage does not prove every labeled sequence is present; an MS match for one component does not describe the impurity load of the others. Credible blend dossiers report both methods and state whether identity is component-resolved.
Net content: total versus per-component; ratio disclosure; names ≠ formulas
Label mass and measured peptide content diverge on blends just as on singles. Water, salts, and counterions can move net peptide content away from the labeled milligram sum. Read the net-content line when present.
Two documentation patterns matter:
- Single total net content. One milligram figure for the whole vial (for example 73.89 mg against a 70 mg labeled GLOW sum). Useful and honest when published that way — it does not report measured milligrams per component.
- Per-component net content. Separate milligram lines for each named peptide. Stronger composition evidence for multi-analyte reagents. Cite category HTML batch pages that show this split as literacy — what stronger blend docs can add — not as a smear or scorecard.
Ratio disclosure is a separate claim. A size string such as 50mg/10mg/10mg or 10mg/10mg is labeled stoichiometry, not proof from a lone HPLC purity percentage. When per-component nets are absent, verify that (a) the labeled ratio is stated unambiguously, (b) measured total net is plausible relative to that sum, and (c) identity evidence supports the named components. Do not invent a per-component milligram table the certificate never printed.
Blend names are not formulas. “GLOW,” “KLOW,” and “CJC + Ipa” are market labels. Two sellers can use the same word at different mass splits. Peptide Foundry’s GLOW convention is GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg; KLOW adds KPV 10 mg. Always read component↔mass mapping on the lot in hand. Identity depth: What is the GLOW research blend? and GLOW vs KLOW.
Factual category exemplar (no ranking implied): Oath Research publishes HTML batch lab-results pages with Freedom Diagnostics accession, HPLC-UV purity, LC-MS identity, and split net peptide content — separate milligram lines per component. That is what stronger blend documentation can look like. Apply the same checklist to every supplier, including Peptide Foundry.
Red flags for a lone “blend purity %”
Pause until the vendor supplies lot-matched, method-stated evidence from a named laboratory:
- A single “blend purity %” with no component list and no lot number
- Purity without method or wavelength
- Exactly 100.00% purity with no chromatogram
- Identity asserted without MS, LC-MS, or a stated HPLC attribution method
- A labeled multi-peptide ratio with no way to tell whether net content is total-only or per-component
- The same PDF reused across different ratios, vial sizes, or batches
- Unnamed laboratory, or a “verify” path that resolves only on the vendor domain with no lab-portal record
- Marketing synonymy (“same as GLOW,” “KLOW equivalent”) offered instead of CAS / mass / certificate fields
Any one is enough to delay a purchase. “Third-party tested” without a named lab and lot number remains an unfinished claim — on blends even more than on singles.
Worked examples: GLOW, KLOW, and CJC-1295 + Ipamorelin
Tables match live Peptide Foundry COA panels at writing time. Confirm against current gated product pages if a lot rotates. Do not invent per-component milligram splits Peptide Foundry has not published.
GLOW — lot FO996
Three-component co-lyophilized blend. PF size 50mg/10mg/10mg (GHK-Cu / BPC-157 / TB-500; 70 mg labeled total).
| Field | Value |
|---|---|
| Lot | FO996 |
| Size | 50mg/10mg/10mg |
| Laboratory | ILS Laboratories |
| Purity | 99.65% (HPLC @ 214 nm) |
| Net peptide content | 73.89 mg (single total on the published panel) |
| Access code | QY5NMBMV |
FO996 reading notes: size string states the intended ratio; HPLC states method and wavelength; net is a single total (73.89 mg versus 70 mg labeled). Portal-verify QY5NMBMV on the ILS portal. Component CAS / ratio literacy: What is the GLOW research blend? Soft handoff: GLOW.
KLOW — lot FO993
Four-component co-lyophilized blend. PF size 50mg/10mg/10mg/10mg (same three masses as GLOW plus KPV 10 mg; 80 mg labeled total).
| Field | Value |
|---|---|
| Lot | FO993 |
| Size | 50mg/10mg/10mg/10mg |
| Laboratory | ILS Laboratories |
| Purity | 99.61% (HPLC @ 214 nm) |
| Net peptide content | 82.4 mg (single total on the published panel) |
| Access code | RATK8CGX |
FO993 adds a fourth named analyte. Confirm all four names on label and certificate before treating purity as sufficient. Net is a published single total (82.4 mg versus 80 mg labeled). Portal code RATK8CGX. Context: What is the KLOW research blend? · GLOW vs KLOW. Soft handoff: KLOW.
CJC-1295 + Ipamorelin — lot FO309
Two-component blend panel. PF size 10mg/10mg (20 mg labeled sum).
| Field | Value |
|---|---|
| Lot | FO309 |
| Panel / size | 10mg/10mg |
| Laboratory | ILS Laboratories |
| Purity | 99.12% (HPLC @ 214 nm) |
| Net peptide content | 20.79 mg (single total on the published panel) |
| Access code | UJ9AVS5F |
Honesty about what this panel publishes: FO309 reports a single HPLC purity percentage and a single net-content total (20.79 mg against a 20 mg labeled sum). Do not invent per-component milligram splits Peptide Foundry has not published. Stronger blend certificates can add per-component nets and MS / LC-MS identity for both sequences — the Oath Research HTML batch-page pattern above is a factual exemplar. Portal-verify with UJ9AVS5F. Identity depth: CJC-1295 + Ipamorelin. Soft handoff: CJC-1295 + Ipamorelin.
Side-by-side summary
| Material | Lot | Size | Purity @ 214 nm | Net (published) | Access code | Lab |
|---|---|---|---|---|---|---|
| GLOW | FO996 | 50/10/10 | 99.65% | 73.89 mg total | QY5NMBMV | ILS |
| KLOW | FO993 | 50/10/10/10 | 99.61% | 82.4 mg total | RATK8CGX | ILS |
| CJC + Ipa | FO309 | 10mg/10mg | 99.12% | 20.79 mg total | UJ9AVS5F | ILS |
All three exemplars share the same honesty pattern: named lab, stated HPLC wavelength, lot-matched access code, and a published net that is a single total. That is real evidence — and the place where stronger blend dossiers can still add component-resolved nets and MS attribution without fabricating unpublished numbers.
Lab-portal verify steps (blend lots)
Supplier PDFs are documents the supplier controls. Laboratory portal records are not. When an access code appears on a Peptide Foundry blend panel, use it.
- Note the lot and access code on the COA or product panel (QY5NMBMV, RATK8CGX, UJ9AVS5F).
- Open the issuing laboratory’s verification portal — type the lab domain yourself; do not blindly trust a vendor QR that lands on a reseller site.
- Enter the access code.
- Confirm blend name, lot, purity, test date, and any net-content line match the document you were given.
- If portal and PDF disagree, trust neither until the laboratory or vendor resolves the mismatch in writing.
Full single-SKU tutorial: How to read a research-peptide COA. Use this page when the material is a multi-peptide blend and you need the extra composition checks. Upstream vendor criteria: USA research-peptide vendor criteria.
FAQ
Is a single blend purity percentage enough?
No — not by itself. It can be one useful line when method, wavelength, lot, and lab are stated. Multi-peptide vials still need a clear component list, identity evidence for those components, ratio disclosure, and preferably portal verification.
Why do some blend panels show only one net milligram figure?
Labs and vendor panels sometimes publish a single total net peptide content. That is honest aggregate evidence, not a per-component assay. Do not invent milligram splits from a total. Treat published totals as totals; ask for per-component nets when assay documentation requires them.
Does HPLC-RTM prove every peptide is present?
HPLC-RTM is a stated retention-time identity method — stronger than an unnamed “Pass,” but not the same as per-component MS / LC-MS. Read the method line you have; weight MS attribution higher when both are present.
Can two vendors sell “GLOW” with different ratios?
Yes. Blend names are market labels, not registry formulas. Compare labeled milligrams and certificates — not the acronym. Peptide Foundry conventions are on the GLOW and KLOW research pages linked above.
Where does Oath Research fit in this article?
As a factual documentation exemplar: public HTML batch pages with per-component net content for multi-peptide lots. That teaches what stronger blend paperwork can include — not a grade, smear, or ranking versus Peptide Foundry or any other seller.
Does a full QC panel replace blend composition checks?
No. Heavy metals, sterility, endotoxin, and illicit screens answer contamination questions. They do not replace component identity or net / ratio literacy on a multi-peptide vial.
Can this material be used outside a laboratory?
No. Research peptides discussed here are supplied for in-vitro and laboratory research by qualified researchers and for no other purpose. They are not drugs, not supplements, and not for human or veterinary use.
Next steps
Practice on live blend panels (account required for the storefront; research library stays open):
- GLOW — lot FO996; three-component blend COA panel
- KLOW — lot FO993; four-component blend COA panel
- CJC-1295 + Ipamorelin — lot FO309; two-component panel with single published net total
Related reading: How to read a research-peptide COA, What is the GLOW research blend?, What is the KLOW research blend?, GLOW vs KLOW, BPC-157 vs TB-500 (shared GLOW/KLOW components), CJC-1295 + Ipamorelin, USA research-peptide vendor criteria, and GHK-Cu research identity.
Research use only. Nothing on this page describes or implies use in humans or animals. Materials are supplied for in-vitro and laboratory research by qualified researchers and for no other purpose.
